Original Source(s)
Related Content
Female patients less likely to receive invasive care
Review identifies recurring sex-based differences across specialties, including lower use of intensive and guideline-compliant treatment among female patients.
September 23, 2026
-
5 min
How do multifood allergy treatments compare?
Investigators compared omalizumab with omalizumab-facilitated multiallergen oral immunotherapy.
September 30, 2026
-
4 min
FDA expands bladder cancer therapy approval
The expansion offers another treatment option for patients with high-grade tumors following BCG failure.
by Mouj Hijazi
October 14, 2026
-
3 min
